| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.002 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.002 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.002 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.002 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.5 | 0.003 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |